trending Market Intelligence /marketintelligence/en/news-insights/trending/2bi6tAHYmH9NRDOyj1_5zg2 content esgSubNav
In This List

Oncimmune replaces outgoing CFO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Oncimmune replaces outgoing CFO

Oncimmune Holdings PLC director and CFO Andrew Millet has stepped down but will remain with the company for six months to ensure an orderly transition.

The company appointed Matthew Hall to replace Millet. Hall recently served as CFO at Tusk Therapeutics and Simbec-Orion Group.

Oncimmune is an early-cancer detection company.